Quick Takeaways
- Neil Kumar filed SCHEDULE 13G/A for BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO).
- Disclosed ownership: 4.6%.
- Date of event: 31 Mar 2026.
Neil Kumar - 31 Mar 2026 SCHEDULE 13G/A Report for BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO)
- Filing Manager
- Neil Kumar
- Reporting Manager
- NEIL KUMAR
- Symbol
- BBIO
- Shares outstanding
- 201,803,957 shares
- Disclosed Ownership
- 9,282,982 shares
- Ownership
- 4.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 16 Apr 2026, 16:35:49 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 13 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Neil Kumar disclosed 4.6% ownership in BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO) on 31 Mar 2026."
What Changed
- Previous schedule filing date: 13 Feb 2025.
- Current filing was accepted on 16 Apr 2026, 16:35.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| NEIL KUMAR | 4.6% | 9,282,982 | 4,208,849 | 5,074,133 | /s/ Neil Kumar | Neil Kumar |